Task Forces and Guidelines
ERS provides financial support to groups of members looking to form a task force to produce Guidelines, Statements and Technical Standards. Once published, the documents provide clarity and direction for a number of topics in respiratory medicine with the aim of improving clinical practice.
All ERS members are eligible to apply for funding to set up a Task Force.
What are Task Forces?
Task Forces are ad hoc groups set up to address a specific issue in respiratory medicine. They aim to produce Clinical Practice Guidelines, Statements or Technical Standards that then are adopted as official ERS documents on issues related to respiratory medicine.
The ERS also encourages the development of joint documents with other socities. ERS members involved in a Task Force with another society are therefore encouraged to contact the ERS Guidelines Working Group (at firstname.lastname@example.org) to discuss the opportunity to develop a joint project.
Once published, manuscripts developed by ERS Task Forces are made available on the ERS E-learning website.
How to apply for funding
ERS Task Forces (not joint with the ATS)
ERS accepts applications for new Task Forces twice a year:
- 1 February
- 1 June
Priority will be given to projects which aim to develop official ERS Clinical Practice Guidelines.
Important: only proposals fully filled in (including Task Force members' Conflict of Interest (COI) forms) will be reviewed. Applicants who submit an incomplete proposal will be asked to resubmit it at the next deadline. Should you have any questions regarding the application form, please do not hesitate to contact the ERS Office prior to the deadline.
- ERS Task Force Guideline and Application Form (for ERS only projects)
- ERS Conflict of Interest and Confidentiality Form
- List of frequently asked questions on ERS document development.
ERS/ATS joint Task Forces
The next deadline to submit an ERS/ATS Task Force proposal is July 2019 (late submissions will not be accepted).
You may refere to the following files for further instructions:
Should you have any question on joint ERS/ATS task force proposal, please contact email@example.com.
All ERS members are eligible to apply for funding to set up a Task Force aiming to develop Clinical Practice Guidelines, Statements or Technical Standard Assessments.
Task Forces joint with other societies (except ATS)
ERS also encourages the development of joint documents with other societies. If you are an ERS member involved in a Task Force with another society, contact the ERS Guidelines Working Group (at firstname.lastname@example.org) to discuss the opportunity to develop an official joint project.
For any other questions, please contact the ERS office at email@example.com.
Methodological Support and patients' involvement
- Useful resources for ERS guidelines developers
- A step by step guide of the GRADE approach
- Guide for chairs on involving patients in Task Forces
The ERS has two in-house methodologists who can help the Task Force Chairs apply a correct methodology throughout their Task Force development. They can also be contacted for any questions relating to the completion of an application. Any questions for the ERS methodologists can be sent to firstname.lastname@example.org.
SUGGESTED TIMELINES TO DEVELOP TASK FORCE DOCUMENTS:
The ERS Science Council recommends to use the AGREE tool to develop Guidelines. Please consult the AGREE website.
Ongoing Task Forces
|Task Force Number||Task Force Name||Task Force Chairs|
|TF-2018-16||Statement on: Treatment of Lung Cancer Stage 1A||Mina Gaga, Hans-Ulrich Kauczor|
|TF-2018-15||Statement on: Lung Cancer Stage 1A||Nir Peled, Hans-Ulrich Kauczor|
|TF-2018-08||Statement on: ERS Statement on diagnosis and investigation of central sleep apnoea in children aged 1 month to 18 years||Hui-Leng Tan|
|TF-2018-07||Techincal Standards on: Developing Lung Function Initiative (GLI) reference equations for exhaled and nasal nitric oxide||Anh-Tuan Dinh-Xuan, Graham Hall|
|TF-2018-05||Statement on: Thoracic Ultrasound Clinical Practice Guidelines||Christian B. Laursen, Nick Maskell|
|TF-2018-04||Statement on: Chronic Thromboembolic Pulmonary Hypertension||Marion Delcroix, Gerald Simonneau, Mayer Eckhard|
|TF-2018-03||Guidelines on: Task force on bronchiectasis guideline in children||Ahmad Kantar, Anne Chang|
|TF-2018-02||Guidelines on: Diagnosis of Asthma in adults||Louis Renaud, Usmani Omar|
|TF-2018-01||Guidelines on: Non-CPAP Therapies for Obstructive Sleep Apnoea||Winfried Randerath, Johan Verbraecken|
|TF-2017-09||Statement on: Updated technical standards for spirometry||Brian Graham, Irene Steenbruggen|
|TF-2017-06||Guidelines on: Evidence based clinical practice guideline on the diagnosis of asthma in children aged 5 to 16 years||Erol Gaillard, Alexander Moller|
|TF-2017-04||Statement on: ERS Statement for the Interpretation of Nitric Oxide Uptake in the Lung||Anh-Tuan Dinh-Xuan, Gerald Zavorsky|
|TF-2017-03||Guidelines on: International Guidelines for the management of severe Community acquired pneumonia||Antoni Torres, Ignacio Martin-Loeches|
|TF-2017-01||Guidelines on: Long term non-invasive ventilation in chronic obstructive pulmonary disease||Wolfram Windisch, Raffaele Scala|
|TF-2016-23||Statement on: Development of ERS/TSANZ Statement - Care of patients with airways disease during pregnancy||Peter Middleton, Vibeke Backer|
|TF-2016-22||Guidelines on: ERS Cough Guidelines 2017||Alyn Morice, Eva Millqvist|
|TF-2016-21||Statement on: Tracheomalacia and bronchomalacia in children||Kostas Priftis, Colin Wallis|
|TF-2016-16||Guidelines on: International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma||Fernando Holguin, Andy Bush|
|TF-2016-10||Guidelines on: Sarcoidosis treatment||Bob Baughman, Dominique Valeyre|
|TF-2016-08||Statement on: Sleepiness and fitness to drive in patients with obstructive sleep apnea||Maria Bonsignore, Walter McNicholas|
|TF-2016-07||Statement on: Standardizing definitions and outcome measures in acute bronchiolitis||Ricardo Fernandes, Mark Everard|
|TF-2016-05||Statement on: Sleep disorders and Stroke||Claudio Bassetti, Winfried Randerath|
|TF-2016-01||Statement on: Chest imaging in Acute Respiratory Failure||Davide Chiumello, Paolo Navalesi|
|TF-2015-19||Statement on: Global Lung Function Initiative (GLI): Deriving global multi-ethnic reference values for the measurement of lung volumes||Graham Hall, Brendan Cooper|
|TF-2015-18||Guidelines on: Long term management of bronchopulmonary dysplasia||Liesbeth Duijts, Marielle Pijnenburg, Charles Roehr|
|TF-2015-16||Statement on: Understanding of and Adherence to International Guidelines in the Management of Stable Asthma by Non-Specialists. Indications for Specialist Referral||Mathioudakis Alexandros, Olympia Tsilochristou, Christer Janson, Ioana Agache|
|TF-2015-06||Statement on : Severe Asthma||Mina Gaga|
|TF-2014-23||Guidelines on : European guidelines from the ERS-EACTS-ESTRO for the management of Malignant Pleural Mesothelioma patients||Giuseppe Cardillo, Arnaud Sherpereel|
|TF-2014-21||Guidelines on : MDR TB Guidelines||Giovanni Battista Migliori, Payam Nahid|
|TF-2014-17||Techincal Standard on : ATS/ERS Statement on Technical Standards for The Forced Oscillation Technique||Gregory King, Ellie Oostveen|
|TF-2014-02||Technology reviews, assesments and standards on : TF-Diagnosis Sleep Disordered Breathing||Renata Riha, Wilfried de Backer|
|TF-2013-15||Guidelines on : The management of diseases caused by non-tuberculous mycobacteria||C. Lange, J. Van Ingen|
|TF-2013-13||Statement on : Functional evaluation of lung and airways: building a flow chart for a comprehensive, multifaceted, evidence-based use of the different techniques||Andrea Aliverti, W. De Backer|
|TF-2013-08||Statement on : Thoracic complications of connective tissue diseases: a consensus statement||Athol Wells, Chris Denton|